Part 3: Asthma treatment in 2024: Navigating the new recommendations for every age After exploring diagnostic changes and the pivotal role of Fractional exhaled Nitric Oxide (FeNO) in asthma care, part 3 of our series shifts the focus to treatment...
Weiterlesen
Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?
Part 2: Why FeNO first? Spotlight on testing & special cases In Part 1, we explored the redefined approach to asthma diagnosis under the new NICE/BTS/SIGN guidelines. In Part 2, we dive deeper into the role of Fractional exhaled Nitric...
Weiterlesen
Practical insights for asthma care: The new NICE/BTS/SIGN guidelines. Why FeNO first?
Part 1: Understanding the changes – Asthma diagnosis & first steps in the new guidelines In light of the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont® Scientific Limited sponsored an...
Weiterlesen
Bedfont® Scientific Limited and Aerosol Medical Systems partner, expanding access to FeNO testing in Latin America
The NObreath® device enhances access to FeNO diagnostics in Mexico. Bedfont® Scientific Limited, a world leader in breath analysis with nearly 50 years of expertise in the medical breath analysis industry, has formed a strategic partnership with Aerosol Medical Systems...
Weiterlesen
Winter is coming: preparing asthma patients with FeNO monitoring
Research has shown that seven out of ten people with asthma report that cold air exacerbates their asthma symptoms1. As winter approaches quickly, it is essential to prepare for asthma management in advance. A vital tool in asthma management, as...
Weiterlesen
Stoptober success: leveraging CO monitoring for effective quitting
Stoptober, launched by Public Health England (PHE) in 2012, is a national smoking cessation campaign that takes place every October, designed to encourage smokers to quit smoking for 28 days. Research has shown that if you can stop smoking for...
Weiterlesen
Categories
